🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 04/09/1996 | 0,1908 USD |
| 06/06/1996 | 0,1622 USD |
| 06/03/1996 | 0,1622 USD |
| 06/12/1995 | 0,1622 USD |
| 05/09/1995 | 0,1622 USD |
| 02/06/1995 | 0,1431 USD |
| 03/03/1995 | 0,1431 USD |
| 02/12/1994 | 0,1431 USD |
| 02/09/1994 | 0,1431 USD |
| 02/06/1994 | 0,1336 USD |
| 02/03/1994 | 0,1336 USD |
| 02/12/1993 | 0,1336 USD |
| 02/09/1993 | 0,1336 USD |
| 02/06/1993 | 0,1193 USD |
| 02/03/1993 | 0,1193 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/10/2006 | 40,08 | 40,35 | 39,89 | 40,02 | -0,12% | 1,17% | 11.455.898 |
| 03/10/2006 | 40,01 | 40,33 | 39,84 | 40,07 | +0,77% | 1,24% | 9.842.502 |
| 02/10/2006 | 40,22 | 40,31 | 39,76 | 39,76 | -0,55% | 1,38% | 9.598.946 |
| 29/09/2006 | 40,02 | 40,28 | 39,77 | 39,98 | -0,38% | 1,26% | 11.391.760 |
| 28/09/2006 | 40,51 | 40,56 | 39,99 | 40,13 | -0,80% | 1,41% | 7.967.734 |
| 27/09/2006 | 40,08 | 40,55 | 39,90 | 40,46 | +1,53% | 1,64% | 13.277.217 |
| 26/09/2006 | 39,90 | 40,19 | 39,47 | 39,85 | -0,48% | 1,82% | 12.673.674 |
| 25/09/2006 | 40,22 | 40,43 | 39,98 | 40,04 | -0,19% | 1,12% | 9.986.602 |
| 22/09/2006 | 40,05 | 40,26 | 39,92 | 40,11 | +0,21% | 0,83% | 9.887.670 |
| 21/09/2006 | 40,02 | 40,10 | 39,67 | 40,03 | +0,02% | 1,07% | 6.873.727 |
| 20/09/2006 | 39,28 | 40,09 | 39,27 | 40,02 | +1,85% | 2,09% | 10.111.838 |
| 19/09/2006 | 39,16 | 39,40 | 38,86 | 39,29 | +0,93% | 1,39% | 8.178.278 |
| 18/09/2006 | 38,98 | 39,11 | 38,72 | 38,93 | -0,73% | 1,00% | 6.829.397 |
| 15/09/2006 | 39,31 | 39,56 | 39,08 | 39,22 | +0,17% | 1,21% | 8.089.512 |
| 14/09/2006 | 39,20 | 39,47 | 39,03 | 39,15 | -0,15% | 1,12% | 7.857.485 |
| 13/09/2006 | 39,17 | 39,66 | 38,94 | 39,21 | -2,51% | 1,83% | 13.038.902 |
| 12/09/2006 | 39,58 | 40,30 | 39,56 | 40,22 | +2,08% | 1,86% | 9.654.176 |
| 11/09/2006 | 38,84 | 39,48 | 38,84 | 39,40 | +0,56% | 1,65% | 5.214.429 |
| 08/09/2006 | 38,07 | 39,38 | 38,07 | 39,18 | +1,03% | 3,43% | 5.173.557 |
| 07/09/2006 | 39,50 | 39,55 | 38,65 | 38,78 | -1,84% | 2,29% | 7.264.841 |
| 06/09/2006 | 39,13 | 39,59 | 38,86 | 39,50 | +0,56% | 1,88% | 7.874.358 |
| 05/09/2006 | 39,11 | 39,30 | 38,74 | 39,28 | +0,51% | 1,44% | 6.704.999 |
| 01/09/2006 | 38,66 | 39,15 | 38,51 | 39,08 | +1,01% | 1,65% | 5.997.390 |
| 31/08/2006 | 38,94 | 39,09 | 38,50 | 38,69 | -0,61% | 1,52% | 7.249.750 |
| 30/08/2006 | 39,06 | 39,36 | 38,84 | 38,93 | -1,14% | 1,34% | 8.223.656 |
| 29/08/2006 | 39,03 | 39,48 | 38,87 | 39,38 | +0,78% | 1,54% | 11.130.808 |
| 28/08/2006 | 38,41 | 39,33 | 38,37 | 39,07 | +1,26% | 2,51% | 9.309.279 |
| 25/08/2006 | 37,98 | 38,86 | 37,98 | 38,59 | +0,95% | 2,34% | 8.289.051 |
| 24/08/2006 | 38,95 | 39,01 | 38,12 | 38,23 | -0,99% | 2,28% | 12.591.720 |
| 23/08/2006 | 38,02 | 38,73 | 37,96 | 38,61 | +1,79% | 2,03% | 11.306.243 |